1. Home
  2. ACHL vs OM Comparison

ACHL vs OM Comparison

Compare ACHL & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • OM
  • Stock Information
  • Founded
  • ACHL 2016
  • OM 2003
  • Country
  • ACHL United Kingdom
  • OM United States
  • Employees
  • ACHL N/A
  • OM N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ACHL Health Care
  • OM Health Care
  • Exchange
  • ACHL Nasdaq
  • OM Nasdaq
  • Market Cap
  • ACHL 46.8M
  • OM 44.0M
  • IPO Year
  • ACHL 2021
  • OM 2020
  • Fundamental
  • Price
  • ACHL $1.14
  • OM $0.79
  • Analyst Decision
  • ACHL Buy
  • OM Strong Buy
  • Analyst Count
  • ACHL 2
  • OM 3
  • Target Price
  • ACHL $4.00
  • OM $4.00
  • AVG Volume (30 Days)
  • ACHL 266.7K
  • OM 1.5M
  • Earning Date
  • ACHL 11-14-2024
  • OM 02-19-2025
  • Dividend Yield
  • ACHL N/A
  • OM N/A
  • EPS Growth
  • ACHL N/A
  • OM N/A
  • EPS
  • ACHL N/A
  • OM N/A
  • Revenue
  • ACHL N/A
  • OM $114,729,000.00
  • Revenue This Year
  • ACHL N/A
  • OM N/A
  • Revenue Next Year
  • ACHL N/A
  • OM $10.49
  • P/E Ratio
  • ACHL N/A
  • OM N/A
  • Revenue Growth
  • ACHL N/A
  • OM N/A
  • 52 Week Low
  • ACHL $0.63
  • OM $0.44
  • 52 Week High
  • ACHL $1.76
  • OM $5.22
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 55.79
  • OM 38.66
  • Support Level
  • ACHL $1.12
  • OM $0.71
  • Resistance Level
  • ACHL $1.18
  • OM $0.85
  • Average True Range (ATR)
  • ACHL 0.05
  • OM 0.17
  • MACD
  • ACHL -0.00
  • OM -0.05
  • Stochastic Oscillator
  • ACHL 33.33
  • OM 8.63

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Share on Social Networks: